share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144：擬議出售證券
美股sec公告 ·  05/15 23:55
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer Stuart A. Arbuckle is set to sell 69 shares of common stock on 05/15/2024, as per the latest filing. The shares, valued at an aggregate market value of $29,734.17, were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024. The transaction is part of a planned sale that was adopted on 02/28/2023. Over the past three months, a total of 13,441 shares have been sold by the officer, generating gross proceeds of $5,684,086.27.
Vertex Pharmaceuticals Inc. officer Stuart A. Arbuckle is set to sell 69 shares of common stock on 05/15/2024, as per the latest filing. The shares, valued at an aggregate market value of $29,734.17, were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024. The transaction is part of a planned sale that was adopted on 02/28/2023. Over the past three months, a total of 13,441 shares have been sold by the officer, generating gross proceeds of $5,684,086.27.
最新文件顯示，Vertex Pharmicals Inc.高管斯圖爾特·阿巴克爾定於2024年5月15日出售69股普通股。這些股票的總市值爲29,734.17美元，於2024年5月14日通過員工股票購買計劃（ESPP）收購。該交易是2023年2月28日通過的計劃出售的一部分。在過去的三個月中，該官員共出售了13,441股股票，總收益爲5,684,086.27美元。
最新文件顯示，Vertex Pharmicals Inc.高管斯圖爾特·阿巴克爾定於2024年5月15日出售69股普通股。這些股票的總市值爲29,734.17美元，於2024年5月14日通過員工股票購買計劃（ESPP）收購。該交易是2023年2月28日通過的計劃出售的一部分。在過去的三個月中，該官員共出售了13,441股股票，總收益爲5,684,086.27美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。